Home > Insider Trading > Filing (0001127602-20-016380)

Filing Details

Accession Number:: 0001127602-20-016380
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-13 11:02:23
Reporting Period:: 2020-05-11

Accepted Time:: 2020-05-13 11:02:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100682	Charles River Laboratories International Inc.	CRL	Services-Commercial Physical & Biological Research (8731)	061397316

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1141722	C James Foster	251 Ballardvale Street Wilmington MA 01887	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-05-11	3,568	$160.85	263,207	No	4	S	Direct
Common Stock	Disposition	2020-05-11	5,582	$161.84	257,625	No	4	S	Direct
Common Stock	Disposition	2020-05-11	2,025	$162.73	255,600	No	4	S	Direct
Common Stock	Disposition	2020-05-11	4,706	$163.89	250,894	No	4	S	Direct
Common Stock	Disposition	2020-05-11	1,565	$164.43	249,329	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,800	Indirect	2018 GRAT
Common Stock	25,000	Indirect	2019 GRAT
Common Stock	20,000	Indirect	2020 GRAT
Common Stock	750	Indirect	By Trust
Common Stock	2,250	Indirect	By Trust
Common Stock	340	Indirect	By Trust
Common Stock	10,000	Indirect	Held By Spouse

Footnotes

On 04/14/2020, the reporting person contributed 20,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his two adult children.
This transaction was executed in multiple trades at prices ranging from $160.33 to $161.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $161.335 to $162.325. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $162.33 to $163.315. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $163.34 to $164.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $164.33 to $164.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.